Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides.
Myelin proteolipid protein (PLP) can induce a T cell-mediated chronic relapsing autoimmune encephalomyelitis in animals and therefore is a candidate for an antigen involved in the pathogenesis of multiple sclerosis. In this report, evidence is presented that peripheral blood mononuclear cells from certain multiple sclerosis (MS) patients recognize the intact PLP molecule as well as certain synthetic PLP peptides in proliferation assays. PLP-specific T cell lines could be obtained from six of ten MS patients with early relapsing-remitting disease. These lines recognized more than one PLP peptide and the relevant peptides differed among patients. The relevance of these observations to the pathogenesis of MS remains to be determined.
Trotter
J L
JL
Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Hickey
W F
WF
van der Veen
R C
RC
Sulze
L
L
D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D009103:Multiple Sclerosis / Q000276:immunology*; D009185:Myelin Proteins / Q000276:immunology*; D018991:Myelin Proteolipid Protein; D010455:Peptides / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology
D009185:Myelin Proteins; D018991:Myelin Proteolipid Protein; D010455:Peptides